Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
A Controversial Alzheimer’s Drug Has Gone Down in Flames
Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by allegations of poorly done and fraudulent research.
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Controversial Alzheimer's drug trial halted
The trial, which involved patients with mild-to-moderate Alzheimer's disease, failed to show significant improvement in cognition and daily functioning compared to a placebo after 52 weeks, according to a Nov.
Hosted on MSN
9h
Alzheimer's Trials Fail; Blood Test Predicts Tau; Neuroscience Moves to Bluesky
Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...
McKnight's Senior Living
2h
California notes progress in Alzheimer’s support plans, looks toward dementia-capable continuum of care
Guided by the Alzheimer's Disease Prevention and Preparedness Task Force, California has taken “significant” action and made ...
15h
Alzheimer’s disease: toxic protein is turned bad by immune enzyme, mouse study shows
Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.
1d
on MSN
Cassava shares sink on plans to stop Alzheimer's drug studies
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...
FierceBiotech
23h
UPDATED: Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2
Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...
Psychology Today
18h
The Relationship Between Music and Alzheimer’s Disease
Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...
WOLF Wilkes-Barre-Scranton on MSN
4h
Alliance for Aging Research advocates for Medicare coverage of early Alzheimer's drugs
November is National Alzheimer’s Awareness Month.The Alliance for Aging Research is using this month to raise awareness about ...
STAT
1d
Roche’s TIGIT troubles continue, a novel Alzheimer’s target misses the mark, and other biotech news
I spent four crazy years writing about Cassava Sciences. Yesterday, the story ended exactly as I and many others knew it ...
4h
Alzheimer’s Foundation of America offers advice for traveling with loved ones with dementia
The Alzheimer’s Foundation of America is offering tips to help those traveling with a loved one with a dementia-related ...
KAKE.com
6h
Holiday travel and how to keep your loved one with Alzheimer's safe while traveling
Americans 65 and older have Alzheimer’s, which is why it’s so important for us to have tips and tricks for keeping them safe ...
ScienceAlert
4h
Blocking One Key Enzyme May Help Reverse The Effects of Alzheimer's
Using genetic tools, the scientists then blocked TYK2 in the mice with Alzheimer's. This resulted in a reduction in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Cassava
Alector
simufilam
Feedback